ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2020

Should sodium-glucose cotransporter-2 inhibitors be first-line treatment for patients with type 2 diabetes?

Carl van WalravenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.